You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康躍科技(300391.SZ)斥1000萬元設立全資子公司長藥良生
格隆匯 02-09 18:00

格隆匯 2 月 9日丨康躍科技(300391.SZ)公佈,公司基於戰略規劃和業務拓展需求,以自有資金認繳出資人民幣1000萬元設立全資子公司寧夏長藥良生製藥有限公司(“長藥良生”),註冊資本為人民幣1000萬元。

為適應公司戰略規劃及經營發展需求,積極推進公司醫藥健康戰略佈局,公司以自有資金認繳出資設立長藥良生,有利於進一步優化與完善公司現有產業佈局及業務結構,加快公司主營業務轉型,促進公司可持續發展,提高公司綜合競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account